As of January 22, 2025, Oncolytics Biotech (ONCY) has a market cap of $67.825 million USD. According to our data, Oncolytics Biotech is ranked No.7976 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $67.83 M |
-3.30%
|
Dec 31, 2024 | $70.14 M |
-32.59%
|
Dec 29, 2023 | $0.10 B |
-17.18%
|
Dec 30, 2022 | $0.13 B |
17.27%
|
Dec 31, 2021 | $0.11 B |
-41.60%
|
Dec 31, 2020 | $0.18 B |
-50.00%
|
Dec 31, 2019 | $0.37 B |
162.98%
|
Dec 31, 2018 | $0.14 B |
-66.57%
|
Dec 29, 2017 | $0.42 B |
171.43%
|
Dec 30, 2016 | $0.15 B |
-22.22%
|
Dec 31, 2015 | $0.20 B |
-49.06%
|
Dec 31, 2014 | $0.39 B |
-65.81%
|
Dec 31, 2013 | $1.13 B |
-60.46%
|
Dec 31, 2012 | $2.87 B |
0.51%
|
Dec 30, 2011 | $2.86 B |
-41.79%
|
Dec 31, 2010 | $4.91 B |
156.70%
|
Dec 31, 2009 | $1.91 B |
115.70%
|
Dec 31, 2008 | $0.89 B |
-29.65%
|
Dec 31, 2007 | $1.26 B |
-17.70%
|
Dec 29, 2006 | $1.53 B |
-55.15%
|
Dec 30, 2005 | $3.41 B |
1.53%
|
Dec 31, 2004 | $3.36 B |
33.43%
|
Dec 31, 2003 | $2.52 B |
194.02%
|
Dec 31, 2002 | $0.86 B |
-72.21%
|
Dec 31, 2001 | $3.08 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Market Cap | = | ONCY Stock Price | * | ONCY Shares Outstanding |
= | $0.88 | * | 77.07 M | |
= | $67.83 M |